Delivery Order SPE2DB22D3011-SPE2DB26FP7JJ
Award Date 11/4/25
Potential Completion Date 11/5/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Cevimeline HCL 30 mg capsules (100-count units) with a ceiling value of $2,221.57. This firm fixed-price delivery order, which is expected to be completed by July 31, 2025, represents a competitively awarded, non-set-aside contract with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. Cevimeline is a cholinergic medication used to treat dry...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cevimeline HCL 30 mg capsules, with a firm fixed price of $1,038.61 and a period of performance through May 1, 2025. The contract is not set aside and was awarded on April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,967.97 to AmerisourceBergen Drug Corp for Cevimeline HCL 30 mg capsules (100-count units) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Cevimeline is a cholinergic medication used to treat dry mouth associated with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,306.92 firm fixed-price delivery order is for the supply of 4560488341 - Cevimeline HCL 30 mg capsules, a prescription medication. The contract has an ultimate completion date of April 5, 2023 and was awarded on April 4, 2023. AmerisourceBergen, a for-profit organization, is the prime contractor and does not have any set-aside designation. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4561055140 Cevimeline HCL 30 mg capsules. The $3,630.50 firm fixed-price delivery order (SPE2DB23FT69B) has a completion date of May 26, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,918.00 firm fixed-price delivery order is for the supply of 4566374155 - CEVIMELINE HCL 30 MG CAPSULE 100S, a medication used to treat certain symptoms of Sjögren's syndrome. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, with ID SPE2DB22D1017|SPE2DB24FE7GM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,557.03 firm fixed-price delivery order is for the provision of 4562519587 - CEVIMELINE HCL 30 MG CAPSULE 100S, a generic pharmaceutical product. The contract has an ultimate completion date of October 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 units of a pharmaceutical capsule product, with a ceiling value of $3,386.08 and an ultimate completion date of July 14, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Evoxac 30 mg, a pharmaceutical product used to treat dry mouth associated with Sjögren's syndrome. The contract, with a ceiling value of $2,752.58, was competitively awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. This delivery order falls under a firm fixed-price arrangement with no set-aside designation and is performed at the vendor's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,348.95 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Elucirem 5 mmol/10 ml vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's...